About
Camneteq can perform Regulatory Due Diligence (RDD) for investors in the medical device sector by systematically evaluating a target company’s regulatory, quality, and compliance posture against global requirements (ISO 13485, MDSAP, FDA, EU MDR, etc.). The goal is to identify risks, valuation impacts, and post-acquisition priorities.
Below is a structured description of how Camneteq would deliver this service.
1.
Camneteq would apply a multi-layered due diligence framework covering:
This framework is aligned with:
2.
Camneteq evaluates whether the target company has legal and sustainable market access.
Key Activities:
Investor Value:
3.
Camneteq assesses the maturity and robustness of the QMS against:
Focus Areas:
Typical Outputs:
Investor Value:
4.
Camneteq performs a deep dive into design control compliance.
Evaluation Includes:
Red Flags:
Investor Value:
5.
Camneteq evaluates production and supplier control processes.
Key Elements:
MDSAP Lens:
Investor Value:
6.
Camneteq assesses how the company handles real-world product performance and safety.
Areas Reviewed:
Red Flags:
Investor Value:
7.
Camneteq reviews past interactions with regulators and notified bodies.
Includes:
Analysis:
Investor Value:
8.
Camneteq evaluates future regulatory risks and readiness.
Focus:
Investor Value:
9.
Camneteq translates findings into investor-relevant insights.
Deliverables:
Example Categories:
10.
Beyond identifying issues, Camneteq provides:
Investor Value:
11.
Camneteq would deliver:
Detailed Report:
Executive Summary:
Optional:
12.
Camneteq’s value lies in:
Phase 1 – Planning
Phase 2 – Review
Phase 3 – On-site / Virtual Audit
Phase 4 – Analysis
Phase 5 – Reporting
Camneteq performs Regulatory Due Diligence by: